Fiche publication
Date publication
mai 1999
Journal
Cancer letters
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MERLIN Jean-Louis
Tous les auteurs :
Melnikova V, Bezdetnaya L, Belitchenko I, Potapenko A, Merlin JL, Guillemin F
Lien Pubmed
Résumé
Alpha-tocopherol at low concentrations protects biosubstrates from oxidative damage, while at high concentrations it may become toxic. Certain lines of tumor cells are reported to contain higher levels of vitamin E than normal cells. In our study alpha-tocopherol was successfully incorporated by cultured HT29 adenocarcinoma cells, but not by MRC-5 normal fibroblasts. At high concentrations (0.3-1 mM) alpha-tocopherol enhanced meta-tetra(hydroxyphenyl)chlorin (mTHPC)-sensitized photoinactivation of HT29 cells (415 nm), but not that of normal fibroblasts. At none of the concentrations used (0.001-1 mM) did alpha-tocopherol protect cells from photokilling, indicating that lipid peroxidation is of minor importance in mTHPC photoactivity. Our findings encourage the in vivo testing of phenolic antioxidants for selective enhancement of PDT-damage in tumors.
Mots clés
Adenocarcinoma, metabolism, Cell Survival, drug effects, Cells, Cultured, Colonic Neoplasms, metabolism, Dose-Response Relationship, Drug, Dose-Response Relationship, Radiation, Fibroblasts, drug effects, HT29 Cells, Humans, Mesoporphyrins, pharmacology, Photochemotherapy, Photosensitizing Agents, pharmacology, Time Factors, Vitamin E, metabolism
Référence
Cancer Lett.. 1999 May 3;139(1):89-95